Sterigenics raises Nordion buyout offer to $758 mln
May 5 (Reuters) - Canadian medical isotopes supplier Nordion Inc said on Monday that Sterigenics, a sterilization services provider owned by private equity firm GTCR LLC, increased its offer price to $758 million from $727 million.
Nordion shareholders will now be entitled to a cash consideration of $12.25 per share, up 50 cents per share from the earlier offer made on March 28. (Reporting by Ashutosh Pandey in Bangalore; Editing by Sriraj Kalluvila)
© Thomson Reuters 2017 All rights reserved.